Pharsight

Desmopressin Acetate patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7022340 FERRING Pharmaceutical composition as solid dosage form and method for manufacturing thereof
Apr, 2023

(a year ago)

Desmopressin Acetate is owned by Ferring.

Desmopressin Acetate contains Desmopressin Acetate.

Desmopressin Acetate has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Desmopressin Acetate are:

  • US7022340

Desmopressin Acetate was authorised for market use on 08 May, 2008.

Desmopressin Acetate is available in tablet;oral dosage forms.

The generics of Desmopressin Acetate are possible to be released after 30 April, 2023.

Drugs and Companies using DESMOPRESSIN ACETATE ingredient

Market Authorisation Date: 08 May, 2008

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage

DESMOPRESSIN ACETATE family patents

Family Patents